Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.

Identifieur interne : 003775 ( Main/Exploration ); précédent : 003774; suivant : 003776

A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.

Auteurs : Jincun Zhao [République populaire de Chine] ; Wei Wang ; Zhihong Yuan ; Rujing Jia ; Zhendong Zhao ; Xiaojun Xu ; Ping Lv ; Yan Zhang ; Chengyu Jiang ; Xiao-Ming Gao

Source :

RBID : pubmed:17055551

Descripteurs français

English descriptors

Abstract

The spike (S) protein of SARS coronavirus (SARS-CoV) is responsible for viral binding with ACE2 molecules. Its receptor-binding motif (S-RBM) is located between residues 424 and 494, which folds into 2 anti-parallel beta-sheets, beta5 and beta6. We have previously demonstrated that fragment 450-650 of the S protein (S450-650) is predominantly recognized by convalescent sera of SARS patients. The N-terminal 60 residues (450-510) of the S450-650 fragment covers the entire beta6 strand of S-RBM. In the present study, we demonstrate that patient sera predominantly recognized 2 linear epitopes outside the beta6 fragment, while the mouse antisera, induced by immunization of BALB/c mice with recombinant S450-650, mainly recognized the beta6 strand-containing region. Unlike patient sera, however, the mouse antisera were unable to inhibit the infectivity of S protein-expressing (SARS-CoV-S) pseudovirus. Fusion protein between green fluorescence protein (GFP) and S450-650 (S450-650-GFP) was able to stain Vero E6 cells and deletion of the beta6 fragment rendered the fusion product (S511-650-GFP) unable to do so. Similarly, recombinant S450-650, but not S511-650, was able to block the infection of Vero E6 cells by the SARS-CoV-S pseudovirus. Co-precipitation experiments confirmed that S450-650 was able to specifically bind with ACE2 molecules in lysate of Vero E6 cells. However, the ability of S450-510, either alone or in fusion with GFP, to bind with ACE2 was significantly poorer compared with S450-650. Our data suggest a possibility that, although the beta6 strand alone is able to bind with ACE2 with relatively high affinity, residues outside the S-RBM could also assist the receptor binding of SARS-CoV-S protein.

DOI: 10.1016/j.virol.2006.09.022
PubMed: 17055551


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.</title>
<author>
<name sortKey="Zhao, Jincun" sort="Zhao, Jincun" uniqKey="Zhao J" first="Jincun" last="Zhao">Jincun Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Immunology, Peking University Health Science Center, Peking University, 38 Xueyuan Road, Beijing 100083, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Immunology, Peking University Health Science Center, Peking University, 38 Xueyuan Road, Beijing 100083</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wang, Wei" sort="Wang, Wei" uniqKey="Wang W" first="Wei" last="Wang">Wei Wang</name>
</author>
<author>
<name sortKey="Yuan, Zhihong" sort="Yuan, Zhihong" uniqKey="Yuan Z" first="Zhihong" last="Yuan">Zhihong Yuan</name>
</author>
<author>
<name sortKey="Jia, Rujing" sort="Jia, Rujing" uniqKey="Jia R" first="Rujing" last="Jia">Rujing Jia</name>
</author>
<author>
<name sortKey="Zhao, Zhendong" sort="Zhao, Zhendong" uniqKey="Zhao Z" first="Zhendong" last="Zhao">Zhendong Zhao</name>
</author>
<author>
<name sortKey="Xu, Xiaojun" sort="Xu, Xiaojun" uniqKey="Xu X" first="Xiaojun" last="Xu">Xiaojun Xu</name>
</author>
<author>
<name sortKey="Lv, Ping" sort="Lv, Ping" uniqKey="Lv P" first="Ping" last="Lv">Ping Lv</name>
</author>
<author>
<name sortKey="Zhang, Yan" sort="Zhang, Yan" uniqKey="Zhang Y" first="Yan" last="Zhang">Yan Zhang</name>
</author>
<author>
<name sortKey="Jiang, Chengyu" sort="Jiang, Chengyu" uniqKey="Jiang C" first="Chengyu" last="Jiang">Chengyu Jiang</name>
</author>
<author>
<name sortKey="Gao, Xiao Ming" sort="Gao, Xiao Ming" uniqKey="Gao X" first="Xiao-Ming" last="Gao">Xiao-Ming Gao</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17055551</idno>
<idno type="pmid">17055551</idno>
<idno type="doi">10.1016/j.virol.2006.09.022</idno>
<idno type="wicri:Area/PubMed/Corpus">002009</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002009</idno>
<idno type="wicri:Area/PubMed/Curation">002009</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002009</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001E81</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001E81</idno>
<idno type="wicri:Area/Ncbi/Merge">001745</idno>
<idno type="wicri:Area/Ncbi/Curation">001745</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001745</idno>
<idno type="wicri:doubleKey">0042-6822:2007:Zhao J:a:study:on</idno>
<idno type="wicri:Area/Main/Merge">003928</idno>
<idno type="wicri:Area/Main/Curation">003775</idno>
<idno type="wicri:Area/Main/Exploration">003775</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.</title>
<author>
<name sortKey="Zhao, Jincun" sort="Zhao, Jincun" uniqKey="Zhao J" first="Jincun" last="Zhao">Jincun Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Immunology, Peking University Health Science Center, Peking University, 38 Xueyuan Road, Beijing 100083, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Immunology, Peking University Health Science Center, Peking University, 38 Xueyuan Road, Beijing 100083</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wang, Wei" sort="Wang, Wei" uniqKey="Wang W" first="Wei" last="Wang">Wei Wang</name>
</author>
<author>
<name sortKey="Yuan, Zhihong" sort="Yuan, Zhihong" uniqKey="Yuan Z" first="Zhihong" last="Yuan">Zhihong Yuan</name>
</author>
<author>
<name sortKey="Jia, Rujing" sort="Jia, Rujing" uniqKey="Jia R" first="Rujing" last="Jia">Rujing Jia</name>
</author>
<author>
<name sortKey="Zhao, Zhendong" sort="Zhao, Zhendong" uniqKey="Zhao Z" first="Zhendong" last="Zhao">Zhendong Zhao</name>
</author>
<author>
<name sortKey="Xu, Xiaojun" sort="Xu, Xiaojun" uniqKey="Xu X" first="Xiaojun" last="Xu">Xiaojun Xu</name>
</author>
<author>
<name sortKey="Lv, Ping" sort="Lv, Ping" uniqKey="Lv P" first="Ping" last="Lv">Ping Lv</name>
</author>
<author>
<name sortKey="Zhang, Yan" sort="Zhang, Yan" uniqKey="Zhang Y" first="Yan" last="Zhang">Yan Zhang</name>
</author>
<author>
<name sortKey="Jiang, Chengyu" sort="Jiang, Chengyu" uniqKey="Jiang C" first="Chengyu" last="Jiang">Chengyu Jiang</name>
</author>
<author>
<name sortKey="Gao, Xiao Ming" sort="Gao, Xiao Ming" uniqKey="Gao X" first="Xiao-Ming" last="Gao">Xiao-Ming Gao</name>
</author>
</analytic>
<series>
<title level="j">Virology</title>
<idno type="ISSN">0042-6822</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Viral</term>
<term>Antibody Affinity</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Epitopes, B-Lymphocyte</term>
<term>Female</term>
<term>Gene Expression Regulation, Viral</term>
<term>Humans</term>
<term>Membrane Glycoproteins (immunology)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Models, Molecular</term>
<term>Peptidyl-Dipeptidase A (metabolism)</term>
<term>Protein Conformation</term>
<term>Receptors, Virus (metabolism)</term>
<term>SARS Virus (immunology)</term>
<term>SARS Virus (metabolism)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Vero Cells</term>
<term>Viral Envelope Proteins (immunology)</term>
<term>Viral Envelope Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Affinité des anticorps</term>
<term>Animaux</term>
<term>Anticorps antiviraux</term>
<term>Cellules Vero</term>
<term>Conformation des protéines</term>
<term>Déterminants antigéniques des lymphocytes B</term>
<term>Femelle</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (immunologie)</term>
<term>Glycoprotéines membranaires (métabolisme)</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Modèles moléculaires</term>
<term>Peptidyl-Dipeptidase A (métabolisme)</term>
<term>Protéines de l'enveloppe virale (immunologie)</term>
<term>Protéines de l'enveloppe virale (métabolisme)</term>
<term>Récepteurs viraux (métabolisme)</term>
<term>Régulation de l'expression des gènes viraux</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Virus du SRAS (immunologie)</term>
<term>Virus du SRAS (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Receptors, Virus</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Antibodies, Viral</term>
<term>Epitopes, B-Lymphocyte</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Protéines de l'enveloppe virale</term>
<term>Récepteurs viraux</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Antibody Affinity</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Female</term>
<term>Gene Expression Regulation, Viral</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Models, Molecular</term>
<term>Protein Conformation</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Affinité des anticorps</term>
<term>Animaux</term>
<term>Anticorps antiviraux</term>
<term>Cellules Vero</term>
<term>Conformation des protéines</term>
<term>Déterminants antigéniques des lymphocytes B</term>
<term>Femelle</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Modèles moléculaires</term>
<term>Régulation de l'expression des gènes viraux</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The spike (S) protein of SARS coronavirus (SARS-CoV) is responsible for viral binding with ACE2 molecules. Its receptor-binding motif (S-RBM) is located between residues 424 and 494, which folds into 2 anti-parallel beta-sheets, beta5 and beta6. We have previously demonstrated that fragment 450-650 of the S protein (S450-650) is predominantly recognized by convalescent sera of SARS patients. The N-terminal 60 residues (450-510) of the S450-650 fragment covers the entire beta6 strand of S-RBM. In the present study, we demonstrate that patient sera predominantly recognized 2 linear epitopes outside the beta6 fragment, while the mouse antisera, induced by immunization of BALB/c mice with recombinant S450-650, mainly recognized the beta6 strand-containing region. Unlike patient sera, however, the mouse antisera were unable to inhibit the infectivity of S protein-expressing (SARS-CoV-S) pseudovirus. Fusion protein between green fluorescence protein (GFP) and S450-650 (S450-650-GFP) was able to stain Vero E6 cells and deletion of the beta6 fragment rendered the fusion product (S511-650-GFP) unable to do so. Similarly, recombinant S450-650, but not S511-650, was able to block the infection of Vero E6 cells by the SARS-CoV-S pseudovirus. Co-precipitation experiments confirmed that S450-650 was able to specifically bind with ACE2 molecules in lysate of Vero E6 cells. However, the ability of S450-510, either alone or in fusion with GFP, to bind with ACE2 was significantly poorer compared with S450-650. Our data suggest a possibility that, although the beta6 strand alone is able to bind with ACE2 with relatively high affinity, residues outside the S-RBM could also assist the receptor binding of SARS-CoV-S protein.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
<settlement>
<li>Pékin</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Gao, Xiao Ming" sort="Gao, Xiao Ming" uniqKey="Gao X" first="Xiao-Ming" last="Gao">Xiao-Ming Gao</name>
<name sortKey="Jia, Rujing" sort="Jia, Rujing" uniqKey="Jia R" first="Rujing" last="Jia">Rujing Jia</name>
<name sortKey="Jiang, Chengyu" sort="Jiang, Chengyu" uniqKey="Jiang C" first="Chengyu" last="Jiang">Chengyu Jiang</name>
<name sortKey="Lv, Ping" sort="Lv, Ping" uniqKey="Lv P" first="Ping" last="Lv">Ping Lv</name>
<name sortKey="Wang, Wei" sort="Wang, Wei" uniqKey="Wang W" first="Wei" last="Wang">Wei Wang</name>
<name sortKey="Xu, Xiaojun" sort="Xu, Xiaojun" uniqKey="Xu X" first="Xiaojun" last="Xu">Xiaojun Xu</name>
<name sortKey="Yuan, Zhihong" sort="Yuan, Zhihong" uniqKey="Yuan Z" first="Zhihong" last="Yuan">Zhihong Yuan</name>
<name sortKey="Zhang, Yan" sort="Zhang, Yan" uniqKey="Zhang Y" first="Yan" last="Zhang">Yan Zhang</name>
<name sortKey="Zhao, Zhendong" sort="Zhao, Zhendong" uniqKey="Zhao Z" first="Zhendong" last="Zhao">Zhendong Zhao</name>
</noCountry>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Zhao, Jincun" sort="Zhao, Jincun" uniqKey="Zhao J" first="Jincun" last="Zhao">Jincun Zhao</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003775 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003775 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:17055551
   |texte=   A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:17055551" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021